Context Therapeutics Inc (CNTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 94,430 | 14,450 | 35,497 | 49,635 | 291 |
| TOTAL | $97,896 | $16,047 | $37,854 | $51,255 | $299 |
| Non-Current Assets | |||||
| PPE Net | 12 | 16 | 28 | N/A | N/A |
| Investments And Advances | 0 | 0 | 0 | 50 | 50 |
| Other Non-Current Assets | 219 | 0 | 85 | 0 | 118 |
| TOTAL | $231 | $16 | $112 | $50 | $168 |
| Total Assets | $98,127 | $16,063 | $37,966 | $51,306 | $467 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 5,829 |
| Accounts payable and accrued liabilities | 1,452 | 2,383 | 936 | 1,826 | 2,708 |
| Accrued Expenses | 1,189 | 1,809 | 2,216 | 1,207 | 956 |
| TOTAL | $2,748 | $4,192 | $3,208 | $3,033 | $9,548 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 69 |
| Other Non-Current Liabilities | 112 | 0 | 0 | 0 | 7,771 |
| TOTAL | $112 | $N/A | $N/A | $N/A | $7,840 |
| Total Liabilities | $2,861 | $4,192 | $3,208 | $3,033 | $17,388 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 89,704 | 15,966 | 15,966 | 15,966 | N/A |
| Common Shares | 90 | 16 | 16 | 16 | 0 |
| Retained earnings | -94,780 | -68,055 | -44,090 | -29,254 | -18,798 |
| TOTAL | $95,266 | $11,871 | $34,758 | $48,272 | $-16,921 |
| Total Liabilities And Equity | $98,127 | $16,063 | $37,966 | $51,306 | $467 |